Dentium (A145720) Q4 2025 earnings summary

Executive summary

• Revenue for 4Q25 was ₩109.1 billion, down 8% year-over-year due to continued weak demand in key markets.

• Operating profit declined 2% year-over-year to ₩26.5 billion, with profitability pressured by lower sales.

• Net income turned negative at -₩4.6 billion, impacted by one-time asset impairment costs at overseas subsidiaries.

Financial highlights

• EBITDA for 4Q25 was ₩33.2 billion, with fixed cost burden rising amid sales slowdown.

• Gross margin improved to 60.9% from 59.9% year-over-year.

• SG&A expenses decreased 9% year-over-year, with R&D expenses down 71%.

• Operating margin rose to 24.3% from 22.9% year-over-year.

• Pre-tax income dropped 86% year-over-year to ₩4.1 billion.

Outlook and guidance

• Gradual recovery expected in China following VBP 2.0 implementation.

• Domestic sales anticipated to rebound in the second half of 2026.

• Growth momentum in Vietnam and other Asian markets projected to continue.